ENO2 and Parkinson disease: Significantly elevated levels of NSE were observed in the CSF of AD patients, although this biomarker can also be found in the CSF of patients with Parkinson’s disease (PD), concluding that NSE may be a useful indicator of neurodegeneration in these disorders [54].